{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T02:40:11Z","timestamp":1795142411911,"version":"4.10.3"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000142","name":"The Arthritis Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The aim was to describe the design, methods and initial findings of a new Canadian inception cohort of children with JIA, The Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) JIA Registry.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The CAPRI JIA Registry was started in 2017 to collect information prospectively on children enrolled within 3\u2009months of JIA diagnosis across Canada. The registry has a non-traditional modular design, with no artificially set times for registry visits to occur, streamlined multi-method data collection that requires 2\u20134\u2009min per visit, and reports cumulative incidence of treatments, outcomes and adverse events calculated by Kaplan\u2013Meier survival methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 166 patients, enrolled a median of 6\u2009weeks after JIA diagnosis at 10 centres, were included. The median age at diagnosis was 9\u2009years [interquartile range (IQR) 3, 13], 61% were female and 51% had oligoarticular JIA. The median three-variable clinical Juvenile Arthritis Disease Activity Score was 6.5 (IQR 4, 10) at enrolment, and the median time to first attainment of clinically inactive disease (CID) was 24\u2009weeks (by 1\u2009year, 81%). Within 1\u2009year of diagnosis, 70% of patients had started a DMARD and 35% a biologic agent. The rates of adverse events and serious adverse events were 60 and 5.8 per 100 patient-years, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This streamlined and flexible registry minimizes the burden of data collection and interference with clinic operations. Initial findings suggest that treatments for newly diagnosed patients with JIA in Canada have intensified, and now 81% of patients attain CID within 1\u2009year of diagnosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa006","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T20:10:47Z","timestamp":1579551047000},"page":"2796-2805","source":"Crossref","is-referenced-by-count":16,"title":["A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry"],"prefix":"10.1093","volume":"59","author":[{"given":"Michelle","family":"Batthish","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, McMaster University, Hamilton, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-0617","authenticated-orcid":false,"given":"Roberta","family":"Berard","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, Western University, London, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cabral","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Bolaria","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle","family":"Ch\u00e9deville","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, McGill University, Montreal, Quebec"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Duffy","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Ottawa, Ottawa, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Gerhold","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Gerschman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Huber","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Proulx-Gauthier","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, Universit\u00e9 Laval, Laval, Quebec"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dax","family":"Rumsey","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Alberta, Edmonton, Alberta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Shiff","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Soon","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of Toronto, Toronto, Ontario"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bruns","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University de Sherbrooke, Sherbrooke, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Tucker","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Guzman","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for The Canadian Alliance of Pediatric Rheumatology Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"2020092423550304600_keaa006-B1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: a systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Joint Bone Spine"},{"key":"2020092423550304600_keaa006-B2","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B3","first-page":"37","article-title":"Towards stratified medicine in juvenile idiopathic arthritis","volume":"15","author":"Robinson","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"2020092423550304600_keaa006-B4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12969-017-0161-5","article-title":"A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr Rheumatol"},{"key":"2020092423550304600_keaa006-B5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/ken085","article-title":"Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study","volume":"47","author":"Adib","year":"2008","journal-title":"Rheumatology"},{"key":"2020092423550304600_keaa006-B6","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","article-title":"Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis","volume":"63","author":"Nordal","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.24539","article-title":"Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study","volume":"61","author":"Oen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B8","doi-asserted-by":"crossref","first-page":"e000074","DOI":"10.1136\/rmdopen-2015-000074","article-title":"The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort","volume":"1","author":"Sengler","year":"2015","journal-title":"RMD Open"},{"key":"2020092423550304600_keaa006-B9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12969-018-0288-z","article-title":"Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children","volume":"16","author":"Tiller","year":"2018","journal-title":"Pediatr Rheumatol"},{"key":"2020092423550304600_keaa006-B10","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/art.1780400903","article-title":"Connective tissue disease registries","volume":"40","author":"Mayes","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B11","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2014-205372","article-title":"The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort","volume":"74","author":"Guzman","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2020092423550304600_keaa006-B12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","article-title":"The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort","volume":"75","author":"Guzman","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020092423550304600_keaa006-B13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3899\/jrheum.160197","article-title":"Predicting which children with juvenile idiopathic arthritis will have a severe disease course: results from the ReACCh-Out cohort","volume":"44","author":"Guzman","year":"2017","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12969-017-0196-7","article-title":"Growth and weight gain in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort","volume":"15","author":"Guzman","year":"2017","journal-title":"Pediatr Rheumatol"},{"key":"2020092423550304600_keaa006-B15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/acr.23783","article-title":"Prospective determination of the incidence and risk factors of new-onset uveitis in juvenile idiopathic arthritis: the research in arthritis in Canadian children emphasizing outcomes cohort","volume":"71","author":"Lee","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/acr.23236","article-title":"Health-related quality of life in an inception cohort of children with juvenile idiopathic arthritis: a longitudinal analysis","volume":"70","author":"Oen","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/acr.23256","article-title":"Characteristics and course of enthesitis in a juvenile idiopathic arthritis inception cohort","volume":"70","author":"Rumsey","year":"2018","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/j.pain.0000000000001064","article-title":"Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort","volume":"159","author":"Shiff","year":"2018","journal-title":"Pain"},{"key":"2020092423550304600_keaa006-B19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/acr.20044","article-title":"Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort","volume":"62","author":"Oen","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3899\/jrheum.150555","article-title":"A family history of psoriasis in a first-degree relative in children with JIA: to include or exclude?","volume":"43","author":"Chan","year":"2016","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B21","article-title":"Children with enthesitis have worse quality of life, function, and pain, irrespective of their juvenile arthritis category","author":"Rumsey","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3899\/jrheum.100930","article-title":"A new approach to clinical care of juvenile idiopathic arthritis: the Juvenile Arthritis Multidimensional Assessment Report","volume":"38","author":"Filocamo","year":"2011","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","article-title":"The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr Rheumatol"},{"key":"2020092423550304600_keaa006-B24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.rdc.2016.01.007","article-title":"The promise of patient-reported outcomes measurement information system\u2014turning theory into reality: a uniform approach to patient-reported outcomes across rheumatic diseases","volume":"42","author":"Witter","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"key":"2020092423550304600_keaa006-B25","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/art.1780371209","article-title":"Measurement of health status in children with juvenile rheumatoid arthritis","volume":"37","author":"Singh","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B26","first-page":"738","article-title":"The Juvenile Arthritis Quality of Life Questionnaire\u2014development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides","volume":"24","author":"Duffy","year":"1997","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B27","first-page":"226","article-title":"Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care","volume":"27","author":"Feldman","year":"2000","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B28","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3899\/jrheum.091474","article-title":"Evaluation of 21-numbered circle and 10-centimeter horizontal line visual analog scales for physician and parent subjective ratings in juvenile idiopathic arthritis","volume":"37","author":"Filocamo","year":"2010","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","article-title":"Development and validation of a composite disease activity score for juvenile idiopathic arthritis","volume":"61","author":"Consolaro","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B30","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","article-title":"Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis","volume":"72","author":"Mcerlane","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2020092423550304600_keaa006-B31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/acr.20497","article-title":"American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis","volume":"63","author":"Wallace","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B32","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/acr.22393","article-title":"Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score","volume":"66","author":"Consolaro","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2020092423550304600_keaa006-B33","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","article-title":"Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial","volume":"70","author":"Tynj\u00e4l\u00e4","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092423550304600_keaa006-B34","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B35","author":"Gliklich","year":"2014"},{"key":"2020092423550304600_keaa006-B36","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.3899\/jrheum.131536","article-title":"What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study","volume":"41","author":"Guzman","year":"2014","journal-title":"J Rheumatol"},{"key":"2020092423550304600_keaa006-B37","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/art.24539","article-title":"Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study","volume":"61","author":"Oen","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B38","article-title":"Physical activity in Canadian children with juvenile idiopathic arthritis","volume":"70","author":"Tucker","year":"2018","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B39","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","article-title":"Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis","volume":"60","author":"Giannini","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B40","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/ard.2007.087411","article-title":"Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register","volume":"68","author":"Prince","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2020092423550304600_keaa006-B42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kes019","article-title":"Long-term outcome of patients with JIA treated with etanercept, results of the biologic register JuMBO","volume":"51","author":"Minden","year":"2012","journal-title":"Rheumatology"},{"key":"2020092423550304600_keaa006-B43","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.38741","article-title":"Efficacy and safety of adalimumab as the first and second biologic agent in juvenile idiopathic arthritis: the German Biologics JIA Registry","volume":"66","author":"Schmeling","year":"2014","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/kev434","article-title":"Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"55","author":"Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"2020092423550304600_keaa006-B45","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/art.39197","article-title":"Medically significant infections are increased in patients with juvenile idiopathic arthritis treated with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"67","author":"Davies","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2020092423550304600_keaa006-B46","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/rheumatology\/ket248","article-title":"Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register","volume":"52","author":"McErlane","year":"2013","journal-title":"Rheumatology"},{"key":"2020092423550304600_keaa006-B47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13075-018-1780-z","article-title":"Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries","volume":"20","author":"Swart","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2020092423550304600_keaa006-B48","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.30367","article-title":"High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score","volume":"63","author":"Bulatovi\u0107","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2020092423550304600_keaa006-B49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.rhu.0000173616.81928.44","article-title":"Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire","volume":"11","author":"Brunner","year":"2005","journal-title":"J Clin Rheumatol"},{"key":"2020092423550304600_keaa006-B50","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"Wallace","year":"2004","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2796\/33790191\/keaa006.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/2796\/33790191\/keaa006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T03:56:35Z","timestamp":1601006195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/2796\/5734218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,2,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa006","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,2,11]]}}}